August 29, 2023
The Biden administration today unveiled the first 10 drugs selected in the Medicare prescription drug price negotiation program.
The announcement is the next step for the program, which was created as part of the Inflation Reduction Act to help make the most expensive Medicare prescription drugs more affordable.
The medications include products for diabetes, blood clotting, heart failure, Crohn's disease, and arthritis. They were selected because they “have high total spending and are high expenditure, single source drugs without generic or biosimilar competition,” federal officials said. The implementation of the program would affect the costs for 53 million Americans who are enrolled in the Part D prescription drug program.
“The Biden-Harris Administration will continue working to ensure that Americans with Medicare have access to innovative, life-saving treatments at lower costs,” said Xavier Becerra, secretary of the U.S. Department of Health and Human Services.
Here’s what you need to know:
“Our goal with these negotiations is to improve access to some of the costliest drugs for millions of people with Medicare while driving competition and innovation,” said CMS Administrator Chiquita Brooks-LaSure.
The government plans to roll out additional medications to be included in upcoming years.
A fact sheet and news release about the program are available online.
Tags: Federal Advocacy | Regulatory Advocacy | Affordable Prescription Drugs | Medicare
Click on topic below for category-specific news articles.
Support a healthier Pennsylvania.